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ABSTRACT 
DUAL REGULATION OF TELOMERASE ACTIVITY BY HSF1 AND ITS ROLE IN 
PROSTATE CANCER PROGRESSION 
By Keith Douglas Ostergaard Jensen 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University. 
Virginia Commonwealth University, 2006 
Major Director: Shawn Holt, Ph.D., Associate Professor, Departments of 
Pathology, Human Genetics, and Pharmacology and Toxicology 
It has been shown that the key components of the hsp90 chaperone 
complex, including hsp90, p23, hsp70, hsp40, and HOP (p60), associate with 
telomerase; however, their specific roles in telomerase function and tumor 
progression have not yet been defined. HSF1, the primary mammalian heat 
shock protein transcription factor, may affect telomerase activity and 
transformation by regulating the expression of several hsp90 chaperone complex 
proteins in response to stress as well as regulating the transcription of hTERT, 
the protein subunit of telomerase. 
In our in vitro model of prostate cancer progression, as cells progress from 
immortal but non-tumorigenic (P69) to tumorigenic (M2182) and eventually 
metastatic (MI 2) capabilities, both telomerase activity and global chaperone 
protein levels increase. Our hypothesis is that HSF1 affects telomerase activity 
directly at the level of transcription and indirectly at the protein level via its 
regulation of proteins of the hsp90 chaperone complex. Furthermore, 
upregulation of HSF1 and/or members of the hsp90 chaperone complex directly 
contribute to prostate cell transformation and that introduction of chaperone- 
related genes will convert non-tumorigenic prostate cells to a tumorigenic state. 
We have shown that ectopic overexpression of HSF1 induces increased 
expression of endogenous hsp90 in P69 cells. Furthermore, telomerase activity 
in the overexpressing HSF1 cell lines is increased as well and is the end result of 
two disparate, yet ultimately cooperating pathways. However, the increased 
telomerase activity does not correlate with increased tumorigenicity. 
In conjunction with this study, we have overexpressed hTERT in the P69 
cell lines and found that telomerase activity is markedly increased in the absence 
of chaperone upregulation. We propose that the demand for increased folding 
and stability of the exogenous hTERT leads to a recruitment of telomerase 
associated chaperone proteins, which can be measured by increased activity 
after immunoprecipitations and nuclear translocation of hsp90 chaperone 
complex proteins. 
Taken together, these projects indicate a significant role for HSF1 and the 
hsp90 chaperone complex proteins on telomerase activity, and provide evidence 
that each may be a viable target for therapeutic intervention. 





























































































































